LOS ANGELES - A California appeals panel on Jan. 27 reversed a trial court's demurrer on claims of failure to warn, negligence and design defect in an Infuse bone graft off-label lawsuit (John Coleman v. Medtronic, Inc., et al., No. B243609, Calif. App., 2nd Dist., Div. 5; 2014 Cal. App. LEXIS 70).